[go: up one dir, main page]

AU3765897A - Use of a plasminogen activator for the treatment of pulmonary disorders - Google Patents

Use of a plasminogen activator for the treatment of pulmonary disorders

Info

Publication number
AU3765897A
AU3765897A AU37658/97A AU3765897A AU3765897A AU 3765897 A AU3765897 A AU 3765897A AU 37658/97 A AU37658/97 A AU 37658/97A AU 3765897 A AU3765897 A AU 3765897A AU 3765897 A AU3765897 A AU 3765897A
Authority
AU
Australia
Prior art keywords
treatment
plasminogen activator
pulmonary disorders
pulmonary
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37658/97A
Inventor
Jurgen Brodersen Gram
Jorgen Jespersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JESPERSEN JOGEN
JURGEN BRODERSEN GRAM
Original Assignee
JESPERSEN JOGEN
JURGEN BRODERSEN GRAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JESPERSEN JOGEN, JURGEN BRODERSEN GRAM filed Critical JESPERSEN JOGEN
Publication of AU3765897A publication Critical patent/AU3765897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37658/97A 1996-08-14 1997-08-14 Use of a plasminogen activator for the treatment of pulmonary disorders Abandoned AU3765897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK862/96 1996-08-14
DK86296 1996-08-14
PCT/DK1997/000330 WO1998006426A1 (en) 1996-08-14 1997-08-14 Use of a plasminogen activator for the treatment of pulmonary disorders

Publications (1)

Publication Number Publication Date
AU3765897A true AU3765897A (en) 1998-03-06

Family

ID=8098378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37658/97A Abandoned AU3765897A (en) 1996-08-14 1997-08-14 Use of a plasminogen activator for the treatment of pulmonary disorders

Country Status (2)

Country Link
AU (1) AU3765897A (en)
WO (1) WO1998006426A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016005720A (en) * 2013-11-04 2016-11-25 Univ Texas Compositions and methods for administration of an enzyme to a subject's airway.
US20180140547A1 (en) * 2015-05-06 2018-05-24 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
WO2021160092A1 (en) * 2020-02-11 2021-08-19 泰伦基国际有限公司 Method and drug for treating viral pneumonia
WO2021214320A1 (en) 2020-04-23 2021-10-28 Previpharma Consulting Gmbh Plasminogen for use in treating and preventing lung dysfunction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4790305A (en) * 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
ES2051371T3 (en) * 1988-10-04 1994-06-16 Univ Johns Hopkins AEROSOL INHALER.
DK0580685T3 (en) * 1991-04-16 1996-03-04 Boehringer Mannheim Gmbh Pharmaceutical packaging unit containing plasminogen activators for multiple bolus administration
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery

Also Published As

Publication number Publication date
WO1998006426A1 (en) 1998-02-19

Similar Documents

Publication Publication Date Title
AU3339897A (en) Sulphonamide derivatives and their use in the treatment of cns disorders
AU6396598A (en) Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
AU3201095A (en) Substituted thiazoles for the treatment of inflammation
AU3107795A (en) Inhibitors of the benzamidine type
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU2058697A (en) Treatment of sleep disorders
ZA979731B (en) Treatment of asthma.
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU3187595A (en) Compounds for the treatment of restenosis
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU3765897A (en) Use of a plasminogen activator for the treatment of pulmonary disorders
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
AU1853397A (en) Treatment of pulmonary inflammation
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
GB9726223D0 (en) The treatment of materials
AU2713797A (en) Depigmentating agent in the treatment of melasma
AU6222994A (en) Shower head
AU1587295A (en) The treatment of gaseous substances
AU8035098A (en) Cephalosporin compounds, use thereof and intermediate compounds of the same
AU1594397A (en) Use of colostrum for the treatment of constipation
AU5330198A (en) Therapeutic compounds
AU2671895A (en) Bisquinolines for the treatment of malaria
AU1714195A (en) Therapeutic benzonitriles
AU2973997A (en) Use of substituted azaspirane in the treatment of asthma